Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

CUSIP: 007002108

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+41,749,451
Put/Call ratio
185%
SEC-reported price per share
$2.35
Number of holders
96
Value change
+$98,192,610
Number of buys
69
Open additional details 1 more signal available
Number of sells
24
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
9,599,852

Security key

007002108

Report period

Q1 2024

Institutions

96

Top holders

10

Ownership snapshot

Top reported holders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $15,728,845 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $15.73M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $15.73M
RTW INVESTMENTS, LP $7.81M
MORGAN STANLEY $5.29M
COWEN AND COMPANY, LLC $5.13M
BlackRock Finance, Inc. $4.13M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$15,728,845
8,322,140 shares
— 31 Dec 2023
RTW INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$7,814,453
4,134,631 shares
— 31 Dec 2023
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$5,289,749
2,798,809 shares
— 31 Dec 2023
COWEN AND COMPANY, LLC
13F
Company
13F
—
denominator unverified
$5,131,875
2,715,278 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$4,125,256
2,182,675 shares
— 31 Dec 2023
Carlyle Group Inc.
13F
Company
13F
—
denominator unverified
$3,976,924
2,115,385 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
96
Shares
75,135,656
Rows available
96
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q1 2024 holders
96
Holder diff
95
Investor Q1 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .